This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications
FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Mounjaro label, DailyMed (2025) Zepbound label, DailyMed (2025) Ozempic label, DailyMed (2024) Wegovy label, DailyMed (2024) Rybelsus label, DailyMed (2024) Check your cost and coverage, Novo Nordisk Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Most structured wellness plans at Silk Clinics combine ongoing oral antioxidant support with periodic glutathione + vitamin C IV sessions, plus broader vitamin therapy where bloodwork indicates
It is possible that a longer period of follow-up would be required for any differences in HCRU related to therapeutic potency to manifest, and this is a possibility worthy of further study
What are peritoneal pockets in endometriosis
Concluding, whatever the myotendinous junction lesions current therapy (i.e., biological scaffolds, administration of active compounds, electrospinning, self-reorganized constructs (for review see, i.e., [98])), there is still the unresolved problem of the myotendinous junction and bone-tendon junction as extremely specialized tissues, inadequate repair through mechanically and histologically suboptimal scar tissue, decreased functional properties, and greater risk of recurrent injury [98]
